Skip to main content
Top
Published in: Malaria Journal 1/2013

Open Access 01-12-2013 | Methodology

A novel live-dead staining methodology to study malaria parasite viability

Authors: Erica M Pasini, Denise van den Ierssel, Henri J Vial, Clemens HM Kocken

Published in: Malaria Journal | Issue 1/2013

Login to get access

Abstract

Background

Malaria is a major health and socio-economical problem in tropical and sub-tropical areas of the world. Several methodologies have been used to assess parasite viability during the adaption of field strains to culture or the assessment of drug potential, but these are in general not able to provide an accurate real-time assessment of whether parasites are alive or dead.

Methods

Different commercial dyes and kits were assessed for their potential to allow for the real-time detection of whether a blood stage malaria parasite is dead or alive.

Results

Here, a methodology is presented based on the potential-sensitive mitochondrial probe JC-1, which allows for the real-time visualization of live (red staining) and/or dead (absence of red staining) blood stage parasites in vitro and ex vivo. This method is applicable across malaria parasite species and strains and allows to visualize all parasite blood stages including gametocytes. Further, this methodology has been assessed also for use in drug sensitivity testing.

Conclusions

The JC-1 staining approach is a versatile methodology that can be used to assess parasite viability during the adaptation of field samples to culture and during drug treatment. It was found to hold promise in the assessment of drugs expected to lead to delayed death phenotypes and it currently being evaluated as a method for the assessment of parasite viability during the adaptation of patient-derived Plasmodium vivax to long-term in vitro culture.
Appendix
Available only for authorised users
Literature
1.
go back to reference Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379: 413-431. 10.1016/S0140-6736(12)60034-8.CrossRefPubMed Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379: 413-431. 10.1016/S0140-6736(12)60034-8.CrossRefPubMed
2.
go back to reference Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW: The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004, 4: 327-336. 10.1016/S1473-3099(04)01043-6.PubMedCentralCrossRefPubMed Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW: The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004, 4: 327-336. 10.1016/S1473-3099(04)01043-6.PubMedCentralCrossRefPubMed
3.
go back to reference Karunamoorthi K: Vector control: a cornerstone in the malaria elimination campaign. Clin Microbiol Infect. 2011, 17: 1608-1616. 10.1111/j.1469-0691.2011.03664.x.CrossRefPubMed Karunamoorthi K: Vector control: a cornerstone in the malaria elimination campaign. Clin Microbiol Infect. 2011, 17: 1608-1616. 10.1111/j.1469-0691.2011.03664.x.CrossRefPubMed
4.
go back to reference van den Berg H, Zaim M, Yadav RS, Soares A, Ameneshewa B, Mnzava A, Hii J, Dash AP, Ejov M: Global trends in the use of insecticides for vector-borne disease control. Environ Health Perspect. 2012, 120: 577-582. 10.1289/ehp.1104340.PubMedCentralCrossRefPubMed van den Berg H, Zaim M, Yadav RS, Soares A, Ameneshewa B, Mnzava A, Hii J, Dash AP, Ejov M: Global trends in the use of insecticides for vector-borne disease control. Environ Health Perspect. 2012, 120: 577-582. 10.1289/ehp.1104340.PubMedCentralCrossRefPubMed
5.
go back to reference Remarque EJ, Faber BW, Kocken CH, Thomas AW: Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 2008, 24: 74-84. 10.1016/j.pt.2007.12.002.CrossRefPubMed Remarque EJ, Faber BW, Kocken CH, Thomas AW: Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 2008, 24: 74-84. 10.1016/j.pt.2007.12.002.CrossRefPubMed
6.
go back to reference Fernando SD, Rodrigo C, Rajapakse S: Chemoprophylaxis in malaria: drugs, evidence of efficacy and costs. Asian Pac J Trop Med. 2011, 4: 330-336. 10.1016/S1995-7645(11)60098-9.CrossRefPubMed Fernando SD, Rodrigo C, Rajapakse S: Chemoprophylaxis in malaria: drugs, evidence of efficacy and costs. Asian Pac J Trop Med. 2011, 4: 330-336. 10.1016/S1995-7645(11)60098-9.CrossRefPubMed
7.
go back to reference Gosling RD, Okell L, Mosha J, Chandramohan D: The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect. 2011, 17: 1617-1623. 10.1111/j.1469-0691.2011.03660.x.CrossRefPubMed Gosling RD, Okell L, Mosha J, Chandramohan D: The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect. 2011, 17: 1617-1623. 10.1111/j.1469-0691.2011.03660.x.CrossRefPubMed
8.
go back to reference Petersen I, Eastman R, Lanzer M: Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 2011, 585: 1551-1562. 10.1016/j.febslet.2011.04.042.CrossRefPubMed Petersen I, Eastman R, Lanzer M: Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 2011, 585: 1551-1562. 10.1016/j.febslet.2011.04.042.CrossRefPubMed
9.
go back to reference Burrows JN, Chibale K, Wells TN: The state of the art in anti-malarial drug discovery and development. Curr Top Med Chem. 2011, 11: 1226-1254. 10.2174/156802611795429194.CrossRefPubMed Burrows JN, Chibale K, Wells TN: The state of the art in anti-malarial drug discovery and development. Curr Top Med Chem. 2011, 11: 1226-1254. 10.2174/156802611795429194.CrossRefPubMed
10.
go back to reference Kantele A, Jokiranta TS: Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi. Clin Infect Dis. 2011, 52: 1356-1362. 10.1093/cid/cir180.CrossRefPubMed Kantele A, Jokiranta TS: Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi. Clin Infect Dis. 2011, 52: 1356-1362. 10.1093/cid/cir180.CrossRefPubMed
11.
go back to reference Cox-Singh J: Zoonotic malaria: Plasmodium knowlesi, an emerging pathogen. Curr Opin Infect Dis. 2012, 25: 530-536. 10.1097/QCO.0b013e3283558780.CrossRefPubMed Cox-Singh J: Zoonotic malaria: Plasmodium knowlesi, an emerging pathogen. Curr Opin Infect Dis. 2012, 25: 530-536. 10.1097/QCO.0b013e3283558780.CrossRefPubMed
13.
go back to reference Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16: 710-718. 10.1128/AAC.16.6.710.PubMedCentralCrossRefPubMed Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979, 16: 710-718. 10.1128/AAC.16.6.710.PubMedCentralCrossRefPubMed
14.
go back to reference Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC: Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007, 51: 1926-1933. 10.1128/AAC.01607-06.PubMedCentralCrossRefPubMed Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC: Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007, 51: 1926-1933. 10.1128/AAC.01607-06.PubMedCentralCrossRefPubMed
15.
go back to reference Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M: Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004, 48: 1803-1806. 10.1128/AAC.48.5.1803-1806.2004.PubMedCentralCrossRefPubMed Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M: Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004, 48: 1803-1806. 10.1128/AAC.48.5.1803-1806.2004.PubMedCentralCrossRefPubMed
16.
go back to reference Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M: Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005, 49: 3575-3577. 10.1128/AAC.49.8.3575-3577.2005.PubMedCentralCrossRefPubMed Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M: Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005, 49: 3575-3577. 10.1128/AAC.49.8.3575-3577.2005.PubMedCentralCrossRefPubMed
17.
go back to reference Noedl H, Krudsood S, Leowattana W, Tangpukdee N, Thanachartwet W, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Yingyuen K, Sriwichal S, Ohrt C, Knirsch C: In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother. 2007, 51: 651-656. 10.1128/AAC.01023-06.PubMedCentralCrossRefPubMed Noedl H, Krudsood S, Leowattana W, Tangpukdee N, Thanachartwet W, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Yingyuen K, Sriwichal S, Ohrt C, Knirsch C: In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother. 2007, 51: 651-656. 10.1128/AAC.01023-06.PubMedCentralCrossRefPubMed
18.
go back to reference Druilhe P, Moreno A, Blanc C, Brasseur PH, Jacquier P: A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. AmJTrop Med Hyg. 2001, 64: 233-241. Druilhe P, Moreno A, Blanc C, Brasseur PH, Jacquier P: A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. AmJTrop Med Hyg. 2001, 64: 233-241.
19.
go back to reference Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ: Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. AmJTrop Med Hyg. 1993, 48: 739-741. Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ: Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. AmJTrop Med Hyg. 1993, 48: 739-741.
20.
go back to reference Noedl H, Wongsrichanalai C, Wernsdorfer WH: Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 2003, 19: 175-181. 10.1016/S1471-4922(03)00028-X.CrossRefPubMed Noedl H, Wongsrichanalai C, Wernsdorfer WH: Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 2003, 19: 175-181. 10.1016/S1471-4922(03)00028-X.CrossRefPubMed
22.
go back to reference Parapini S, Basilico N, Pasini E, Egan TJ, Olliaro P, Taramelli D, Monti D: Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp Parasitol. 2000, 96: 249-256. 10.1006/expr.2000.4583.CrossRefPubMed Parapini S, Basilico N, Pasini E, Egan TJ, Olliaro P, Taramelli D, Monti D: Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp Parasitol. 2000, 96: 249-256. 10.1006/expr.2000.4583.CrossRefPubMed
23.
go back to reference Kocken CH, Ozwara H, van der Wel A, Beetsma AL, Mwenda JM, Thomas AW: Plasmodium knowlesi provides a rapid in vitro and in vivo transfection system that enables double-crossover gene knockout studies. Infect Immun. 2002, 70: 655-660. 10.1128/IAI.70.2.655-660.2002.PubMedCentralCrossRefPubMed Kocken CH, Ozwara H, van der Wel A, Beetsma AL, Mwenda JM, Thomas AW: Plasmodium knowlesi provides a rapid in vitro and in vivo transfection system that enables double-crossover gene knockout studies. Infect Immun. 2002, 70: 655-660. 10.1128/IAI.70.2.655-660.2002.PubMedCentralCrossRefPubMed
24.
go back to reference Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126/science.781840.CrossRefPubMed Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126/science.781840.CrossRefPubMed
25.
go back to reference van der Wel AM, Tomas AM, Kocken CH, Malhotra P, Janse CJ, Waters AP, Thomas AW: Transfection of the primate malaria parasite Plasmodium knowlesi using entirely heterologous constructs. J Exp Med. 1997, 185: 1499-1503. 10.1084/jem.185.8.1499.CrossRefPubMed van der Wel AM, Tomas AM, Kocken CH, Malhotra P, Janse CJ, Waters AP, Thomas AW: Transfection of the primate malaria parasite Plasmodium knowlesi using entirely heterologous constructs. J Exp Med. 1997, 185: 1499-1503. 10.1084/jem.185.8.1499.CrossRefPubMed
26.
go back to reference Wel A, Kocken CH, Pronk TC, Franke-Fayard B, Thomas AW: New selectable markers and single crossover integration for the highly versatile Plasmodium knowlesi transfection system. Mol Biochem Parasitol. 2004, 134: 97-104. 10.1016/j.molbiopara.2003.10.019.CrossRefPubMed Wel A, Kocken CH, Pronk TC, Franke-Fayard B, Thomas AW: New selectable markers and single crossover integration for the highly versatile Plasmodium knowlesi transfection system. Mol Biochem Parasitol. 2004, 134: 97-104. 10.1016/j.molbiopara.2003.10.019.CrossRefPubMed
27.
go back to reference Kocken CH, van der Wel A, Rosenwirth B, Thomas AW: Plasmodium vivax: in vitro antiparasitic effect of cyclosporins. Exp Parasitol. 1996, 84: 439-443. 10.1006/expr.1996.0132.CrossRefPubMed Kocken CH, van der Wel A, Rosenwirth B, Thomas AW: Plasmodium vivax: in vitro antiparasitic effect of cyclosporins. Exp Parasitol. 1996, 84: 439-443. 10.1006/expr.1996.0132.CrossRefPubMed
28.
go back to reference Borel E, Mayencon M, Kaiser K, Picot S, Peyron F: Fluorogenic detection of viable Toxoplasma gondii. Parasite. 1998, 5: 371-373.CrossRefPubMed Borel E, Mayencon M, Kaiser K, Picot S, Peyron F: Fluorogenic detection of viable Toxoplasma gondii. Parasite. 1998, 5: 371-373.CrossRefPubMed
29.
go back to reference Mendiratta DK, Bhutada K, Narang R, Narang P: Evaluation of different methods for diagnosis of P. falciparum malaria. Indian J Med Microbiol. 2006, 24: 49-51. 10.4103/0255-0857.19895.CrossRefPubMed Mendiratta DK, Bhutada K, Narang R, Narang P: Evaluation of different methods for diagnosis of P. falciparum malaria. Indian J Med Microbiol. 2006, 24: 49-51. 10.4103/0255-0857.19895.CrossRefPubMed
30.
go back to reference Keiser J, Utzinger J, Premji Z, Yamagata Y, Singer BH: Acridine orange for malaria diagnosis: its diagnostic performance, its promotion and implementation in tanzania, and the implications for malaria control. Ann Trop Med Parasitol. 2002, 96: 643-654. 10.1179/000349802125001834.CrossRefPubMed Keiser J, Utzinger J, Premji Z, Yamagata Y, Singer BH: Acridine orange for malaria diagnosis: its diagnostic performance, its promotion and implementation in tanzania, and the implications for malaria control. Ann Trop Med Parasitol. 2002, 96: 643-654. 10.1179/000349802125001834.CrossRefPubMed
31.
go back to reference Kong HH, Chung DI: Comparison of acridine orange and Giemsa stains for malaria diagnosis. Korean J Parasitol. 1995, 33: 391-394. 10.3347/kjp.1995.33.4.391.CrossRefPubMed Kong HH, Chung DI: Comparison of acridine orange and Giemsa stains for malaria diagnosis. Korean J Parasitol. 1995, 33: 391-394. 10.3347/kjp.1995.33.4.391.CrossRefPubMed
32.
go back to reference Sato S, Wilson RJ: The use of DsRED in single- and dual-color fluorescence labeling of mitochondrial and plastid organelles in Plasmodium falciparum. Mol Biochem Parasitol. 2004, 134: 175-179. 10.1016/j.molbiopara.2003.11.015.CrossRefPubMed Sato S, Wilson RJ: The use of DsRED in single- and dual-color fluorescence labeling of mitochondrial and plastid organelles in Plasmodium falciparum. Mol Biochem Parasitol. 2004, 134: 175-179. 10.1016/j.molbiopara.2003.11.015.CrossRefPubMed
33.
go back to reference Tschan S, Kreidenweiss A, Stierhof YD, Sessler N, Fendel R, Mordmuller B: Mitochondrial localization of the threonine peptidase PfHslV, a ClpQ ortholog in Plasmodium falciparum. Int J Parasitol. 2010, 40: 1517-1523. 10.1016/j.ijpara.2010.05.006.CrossRefPubMed Tschan S, Kreidenweiss A, Stierhof YD, Sessler N, Fendel R, Mordmuller B: Mitochondrial localization of the threonine peptidase PfHslV, a ClpQ ortholog in Plasmodium falciparum. Int J Parasitol. 2010, 40: 1517-1523. 10.1016/j.ijpara.2010.05.006.CrossRefPubMed
34.
go back to reference Zhang J, Krugliak M, Ginsburg H: The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs. Mol Biochem Parasitol. 1999, 99: 129-141. 10.1016/S0166-6851(99)00008-0.CrossRefPubMed Zhang J, Krugliak M, Ginsburg H: The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs. Mol Biochem Parasitol. 1999, 99: 129-141. 10.1016/S0166-6851(99)00008-0.CrossRefPubMed
35.
go back to reference Fisher N, Abd Majid R, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O’Neill PM, Ward SA, Biagini GA: Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression. J Biol Chem. 2012, 287: 9731-9741. 10.1074/jbc.M111.324319.PubMedCentralCrossRefPubMed Fisher N, Abd Majid R, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O’Neill PM, Ward SA, Biagini GA: Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression. J Biol Chem. 2012, 287: 9731-9741. 10.1074/jbc.M111.324319.PubMedCentralCrossRefPubMed
36.
go back to reference Moore CM, Hoey EM, Trudgett A, Timson DJ: Artemisinins act through at least two targets in a yeast model. FEMS Yeast Res. 2011, 11: 233-237. 10.1111/j.1567-1364.2010.00706.x.CrossRefPubMed Moore CM, Hoey EM, Trudgett A, Timson DJ: Artemisinins act through at least two targets in a yeast model. FEMS Yeast Res. 2011, 11: 233-237. 10.1111/j.1567-1364.2010.00706.x.CrossRefPubMed
37.
go back to reference O’Neill PM, Barton VE, Ward SA: The molecular mechanism of action of artemisinin–the debate continues. Molecules. 2010, 15: 1705-1721. 10.3390/molecules15031705.CrossRefPubMed O’Neill PM, Barton VE, Ward SA: The molecular mechanism of action of artemisinin–the debate continues. Molecules. 2010, 15: 1705-1721. 10.3390/molecules15031705.CrossRefPubMed
38.
go back to reference Ben Mamoun C, Prigge ST, Vial H: Targeting the lipid metabolic pathways for the treatment of malaria. Drug Dev Res. 2010, 71: 44-55.PubMedCentralPubMed Ben Mamoun C, Prigge ST, Vial H: Targeting the lipid metabolic pathways for the treatment of malaria. Drug Dev Res. 2010, 71: 44-55.PubMedCentralPubMed
39.
go back to reference Kocken CH, Remarque EJ, Dubbeld MA, Wein S, van der Wel A, Verburgh RJ, Vial HJ, Thomas AW: Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria. Antimicrob Agents Chemother. 2009, 53: 421-427. 10.1128/AAC.00576-08.PubMedCentralCrossRefPubMed Kocken CH, Remarque EJ, Dubbeld MA, Wein S, van der Wel A, Verburgh RJ, Vial HJ, Thomas AW: Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria. Antimicrob Agents Chemother. 2009, 53: 421-427. 10.1128/AAC.00576-08.PubMedCentralCrossRefPubMed
40.
go back to reference Wengelnik K, Vidal V, Ancelin ML, Cathiard AM, Morgat JL, Kocken CH, Calas M, Herrera S, Thomas AW, Vial HJ: A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science. 2002, 295: 1311-1314. 10.1126/science.1067236.CrossRefPubMed Wengelnik K, Vidal V, Ancelin ML, Cathiard AM, Morgat JL, Kocken CH, Calas M, Herrera S, Thomas AW, Vial HJ: A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science. 2002, 295: 1311-1314. 10.1126/science.1067236.CrossRefPubMed
41.
go back to reference Vial HJ, Wein S, Farenc C, Kocken C, Nicolas O, Ancelin ML, Bressolle F, Thomas A, Calas M: Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc Natl Acad Sci U S A. 2004, 101: 15458-15463. 10.1073/pnas.0404037101.PubMedCentralCrossRefPubMed Vial HJ, Wein S, Farenc C, Kocken C, Nicolas O, Ancelin ML, Bressolle F, Thomas A, Calas M: Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc Natl Acad Sci U S A. 2004, 101: 15458-15463. 10.1073/pnas.0404037101.PubMedCentralCrossRefPubMed
42.
go back to reference Vial H, Penarete D, Wein S, Caldarelli S, Fraisse L, Peyrottes S: Lipids as drug targets for malaria therapy. Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development. Edited by: Editions B. 2011, Germany: Wiley-VCH Press, 23- Vial H, Penarete D, Wein S, Caldarelli S, Fraisse L, Peyrottes S: Lipids as drug targets for malaria therapy. Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development. Edited by: Editions B. 2011, Germany: Wiley-VCH Press, 23-
43.
go back to reference Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H: Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. J Clin Microbiol. 2010, 48: 1651-1660. 10.1128/JCM.02250-09.PubMedCentralCrossRefPubMed Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H: Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. J Clin Microbiol. 2010, 48: 1651-1660. 10.1128/JCM.02250-09.PubMedCentralCrossRefPubMed
44.
go back to reference Ancelin ML, Calas M, Vidal-Sailhan V, Herbute S, Ringwald P, Vial HJ: Potent inhibitors of plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother. 2003, 47: 2590-2597. 10.1128/AAC.47.8.2590-2597.2003.PubMedCentralCrossRefPubMed Ancelin ML, Calas M, Vidal-Sailhan V, Herbute S, Ringwald P, Vial HJ: Potent inhibitors of plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother. 2003, 47: 2590-2597. 10.1128/AAC.47.8.2590-2597.2003.PubMedCentralCrossRefPubMed
Metadata
Title
A novel live-dead staining methodology to study malaria parasite viability
Authors
Erica M Pasini
Denise van den Ierssel
Henri J Vial
Clemens HM Kocken
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2013
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-12-190

Other articles of this Issue 1/2013

Malaria Journal 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine